Chief Executive Officer, President and Director · Ventyx Biosciences, Inc. (VTYX)

Raju Mohan

A named executive officer of Ventyx Biosciences in every fiscal year CompBrief holds from FY2023 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$1,283,015

Salary $621,920Stock awards $0

FY2023: $9,411,949

2nd of 4 named executive officers at Ventyx Biosciences by FY2024 total.

4 named officers on file for Ventyx Biosciences, FY2024

Raju Mohan’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Ventyx Biosciences’s whole pay program stands against its peers

  • Ventyx Biosciences’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on VTYX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 23, 2025 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Raju Mohan’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Raju Mohan compensation by year

Ventyx Biosciences Summary Compensation Table · all 2 fiscal years held
In US dollars, as Ventyx Biosciences reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2023FY2024
Salary$596,083$621,920
Bonus$0$0
Stock awards$1,524,528$0
Option awards$6,982,128$303,800
Non-equity incentive$296,010$342,045
Pension and deferred compensation$0$0
All other$13,200$15,250
Total$9,411,949$1,283,015

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Ventyx Biosciences, Inc. DEF 14A filed April 23, 2025, accession 0000950170-25-057384, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Ventyx Biosciences, Inc. filed document, accession 0000950170-25-057384. Every figure is read from that document and cited to the page and table it appears in. Filed April 23, 2025.

$9.4M
$1.3M
FY23
FY24
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
RSU116,668$255,503—
RSU35,532$77,815—
Option155,000—$2.49
Option355,313—$2.14
Option107,917—$12.21
Option85,326—$8.04
Option116,668—$14.48
Option148,047—$33.84

Per the Outstanding Equity Awards at Fiscal Year-End table in Ventyx Biosciences, Inc.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

13 Form 4 lines since the FY2024 proxy (filed April 23, 2025)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-03-04Disposition to the issuer—2,372,863—0
2026-03-04Disposition to the issuer derivative—23,688—0
2026-03-04Disposition to the issuer derivative—700,000—0
2026-03-04Disposition to the issuer derivative—155,000—0
2026-03-04Disposition to the issuer derivative—473,750—0
2026-03-04Disposition to the issuer derivative—370,000—0
2026-03-04Disposition to the issuer derivative—335,286—0
2026-03-04Disposition to the issuer derivative—7,972—0

The 8 most recent of 13 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Ventyx Biosciences’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Matthew MooreChief Operating Officer$1,918,110
Raju Mohan · this pageChief Executive Officer, President and Director$1,283,015
Martin AusterFormer Chief Financial Officer$995,179
Mark FormanChief Medical Officer$937,465

Board service

Ventyx Biosciences board · FY2024

How this board is paid

Company policy: Ventyx Biosciences pays directors a $40,000 cash retainer. As stated in Ventyx Biosciences's FY2024 proxy.

The full Ventyx Biosciences compensation record

free company brief

This page is one person within Ventyx Biosciences's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Ventyx Biosciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Raju Mohan's compensation dossier · One-time report. No refunds.